Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 2620-2626, June 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, Q.
Right arrow Articles by Nesland, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, Q.
Right arrow Articles by Nesland, J. M.

Uptake, Localization, and Photodynamic Effect of meso-Tetra(hydroxyphenyl)porphine and Its Corresponding Chlorin in Normal and Tumor Tissues of Mice Bearing Mammary Carcinoma1

Qian Peng2, Johan Moan, Li-Wei Ma and Jahn M. Nesland

Departments of Pathology [Q. P., J. M. N.] and Biophysics [Q. P., J. M., L-W. M.], Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway

By using a chemical extraction assay and confocal laser scanning fluorescence microscopy, the kinetic patterns of uptake, elimination, and localization of meso-tetra(hydroxyphenyl)porphine (m-THPP) and its corresponding chlorin (m-THPC) in tumors and various normal tissues of female C3D2/F1 mice bearing CaD2 mammary carcinoma were studied after an i.p. injection of either 5 mg/kg body weight of m-THPP or 1 mg/kg body weight of m-THPC. Moreover, the histological and ultrastructural alterations of the tumors were evaluated after photodynamic therapy (PDT) with m-THPP or m-THPC. The PDT efficacy with m-THPP and m-THPC was also compared. Both m-THPP and m-THPC had a similar kinetic pattern of distribution in the tumors and most normal tissues examined. The concentrations of the dyes in the tissues peaked at 24–48 h after injection. The peak values of the uptake of m-THPP by the tissues were found to decrease in the following order: spleen > urinary tract > kidney > liver > lung > tumor > heart > skin > muscle > brain. However, higher concentrations of m-THPC were taken up by the tumors than by most of the normal tissues studied except for the liver, urinary tract, and skin. m-THPP was mainly localized in the stroma of the tumors, whereas m-THPC was distributed in both vascular interstitium and neoplastic cells of the tumors. Morphological studies showed that PDT with m-THPP resulted in destructive changes in the microvasculature of the tumors, whereas m-THPC-based PDT destroyed both vascular walls and tumor cells of the tumors. The m-THPP-PDT of the tumors was much less efficient than m-THPC-PDT of the tumors, although the dose of m-THPP used was five times higher than that of m-THPC. m-THPP and m-THPC have different efficiency of sensitizing tumors to photodestruction, although they are similar with respect to hydrophobicity. This is likely due to the differences in their intratumoral localization patterns and in their absorption spectra.

1 This work was supported by The Norwegian Cancer Society and The Association for International Cancer Research.

2 To whom requests for reprints should be addressed, at Department of Biophysics, Institute for Cancer Research, Montebello, 0310 Oslo, Norway.

Received 12/20/94. Accepted 4/17/95.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. A. Groneberg, A. Fischer, K. F. Chung, and H. Daniel
Molecular Mechanisms of Pulmonary Peptidomimetic Drug and Peptide Transport
Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 251 - 260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. A. Groneberg, F. Doring, S. Theis, M. Nickolaus, A. Fischer, and H. Daniel
Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1172 - E1179.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D A Groneberg, P R Eynott, F Doring, Q Thai Dinh, T Oates, P J Barnes, K F Chung, H Daniel, and A Fischer
Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung
Thorax, January 1, 2002; 57(1): 55 - 60.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Peng, T. Warloe, J. Moan, A. Godal, F. Apricena, K.-E. Giercksky, and J. M. Nesland
Antitumor Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy Can Be Enhanced by the Use of a Low Dose of Photofrin in Human Tumor Xenografts
Cancer Res., August 1, 2001; 61(15): 5824 - 5832.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. I. Fielding, G. A. Buonaccorsi, A. J. MacRobert, A. M. Hanby, M. R. Hetzel, and S. G. Bown
Fine-Needle Interstitial Photodynamic Therapy of the Lung Parenchyma: Photosensitizer Distribution and Morphologic Effects of Treatment
Chest, February 1, 1999; 115(2): 502 - 510.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.